Lv1
48 积分 2024-10-14 加入
Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate therapy
10天前
已完结
Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease
11天前
已完结
“Dark Paget” Cells in Extramammary Paget Disease: A Staining Artifact and Diagnostic Pitfall
12天前
已关闭
Single‐agent taxane is useful in palliative chemotherapy for advanced extramammary Paget disease: a case series
12天前
已完结
Efficacy of S‐1 plus docetaxel in the treatment of metastatic extramammary Paget’s disease: a multicentre retrospective study
13天前
已完结
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva
14天前
已完结
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease
14天前
已完结
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study
16天前
已完结
Disitamab Vedotin: First Approval
16天前
已完结
Usefulness of docetaxel as first‐line chemotherapy for metastatic extramammary Paget's disease
17天前
已完结
皖公网安备34019202002308
